Phase 2 Parkinson Disease (PD) Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

18F-mFBG Cardiac Uptake With Lewy Body Dementia

Lewy Body Dementia (LBD)Parkinson Disease (PD)

Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)20 enrolled1 locationNCT07176286

Recruiting

Phase 1Phase 2

Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease

Parkinson Disease (PD)

XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.90 enrolled1 locationNCT07166757